0 Comment(s)
Print
E-mail China.org.cn, November 1, 2024
On Oct. 26, Beijing Love Book Cancer Foundation (LBCF), in collaboration with Beijing Cancer Rehabilitation Society (BCRS), organized an educational event for breast cancer patients in Beijing. The initiative sought to empower patients by deepening their understanding of comprehensive cancer treatments and recovery strategies, thereby encouraging a more positive approach to standardized care.
The event showcased the screening of "Healthy Her," a documentary that delves into the lives of breast cancer patients, offering the public a closer look at daily challenges that patients face. In addition, the gathering featured a walking activity that is a form of therapeutic exercise included as part of a multifaceted approach to recovery.
People participate in a charity walk at Longtan Lake Park in Beijing, China, Oct. 26, 2024. [Photo by Liao Jiaxin/China.org.cn]
Jiang Zefei, vice director of the Department of Oncology at the Fifth Medical Center of the PLA General Hospital, said: "This event is designed to inspire patients to maintain a positive and optimistic outlook in their fight against cancer and to bolster their confidence in returning to societal life."
"We anticipate a future where collaborative efforts from all societal sectors will provide comprehensive support for breast cancer patients, both physically and psychologically," he added.
Breast cancer is a common life-threatening disease that affects women's health in China. As per the data released by China's National Cancer Center, the country reported approximately 357,200 new breast cancer cases in 2022, placing it fifth in mortality rates.
With advancements in standardized treatments and the introduction of innovative drugs and therapies, the five-year survival rate for breast cancer patients diagnosed at early stages in China has surpassed 80%, according to Professor Mo Xueli from Peking University Shougang Hospital.
Professor Shi Anli, honorary director of Cancer Rehabilitation Society of China Anti-Cancer Association (CRS) and a three-time cancer survivor, mentioned the important role of novel medical treatments. Reflecting on her own experiences, she said: "Genetic testing during my third cancer battle enabled highly precise treatment approaches." She further commented on the progress in pharmaceutical development, including immunotherapy and targeted therapy, which have broadened treatment options, improved clinical outcomes and significantly enhanced the psychological well-being of patients.
Professor Mo also emphasized that the government has significantly ramped up its efforts in screening for cervical and breast cancer.
In Jan. 2022, the National Health Commission's Department of Women's and Children's Health released a strategic plan for cervical and breast cancer screenings. For breast cancer, the strategy pushes for the early diagnosis rate to reach over 70% by the end of 2025, aiming to elevate health standards for women.
